Evidence map›Paper›PMID 32664574›Full record

ArticlePharmaceutics2020

Bilayer Mucoadhesive Buccal Film for Mucosal Ulcers Treatment: Development, Characterization, and Single Study Case.

Thais F R Alves, Alesssandra C Rios, Katiusca da Silva Pontes, Decio L Portella, Norberto Aranha, Patricia Severino, Eliana B Souto, Joyce K M Gonsalves, Rogeria de Souza Nunes, Marco V Chaud

Abstract read
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Formulating biopharmaceuticals using three-dimensional printing.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Review
  7. A novel oral medicated jelly for enhancement of etilefrine hydrochloride bioavailability:Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thais F R AlvesLaboratory of Biomaterials and Nanotechnology (LaBNUS), University of Sorocaba, Sorocaba 18023-000, Sao Paulo, Brazil.ORCID 0000-0002-3586-9457
Alesssandra C RiosLaboratory of Biomaterials and Nanotechnology (LaBNUS), University of Sorocaba, Sorocaba 18023-000, Sao Paulo, Brazil.
Katiusca da Silva PontesLaboratory of Biomaterials and Nanotechnology (LaBNUS), University of Sorocaba, Sorocaba 18023-000, Sao Paulo, Brazil.ORCID 0000-0002-8264-9035
Decio L PortellaLaboratory of Biomaterials and Nanotechnology (LaBNUS), University of Sorocaba, Sorocaba 18023-000, Sao Paulo, Brazil.
Norberto AranhaLaboratory of Biomaterials and Nanotechnology (LaBNUS), University of Sorocaba, Sorocaba 18023-000, Sao Paulo, Brazil.
Patricia SeverinoBiotechnological Postgraduate Program, University of Tiradentes (Unit), Aracaju 49010-390, Sergipe, Brazil.ORCID 0000-0001-6527-6612
Eliana B SoutoFaculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.ORCID 0000-0002-9737-6017
Joyce K M GonsalvesDepartment of Pharmacy, Federal University of Sergipe, Saint Christopher, Sergipe 49100-000, Brazil.
Rogeria de Souza NunesDepartment of Pharmacy, Federal University of Sergipe, Saint Christopher, Sergipe 49100-000, Brazil.
Marco V ChaudLaboratory of Biomaterials and Nanotechnology (LaBNUS), University of Sorocaba, Sorocaba 18023-000, Sao Paulo, Brazil.ORCID 0000-0003-3618-8415

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 425271/2016-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2011/21219-5Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/11350-6Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/13432-0
6 · The paper itself

Abstract

The formation of mucosal ulcers is an end result of epithelial damage, and it occurs due to some specific causes, such as trauma, aphthous stomatitis, lichen planus and lichenoid reactions, cytotoxic effects of chemotherapy and radiation, and drug-induced hypersensitivity reactions and malignant settings. This study focused on films for target drug delivery with respect to the treatment of the diseases of the oral mucosa, specifically mucositis. The results of a single clinical study as a pre-experimental design was performed and followed up to the outcome until 30 days. The polymeric film was prepared in a mucoadhesive bilayer structure: the basal layer with lidocaine HCl had a faster release than the apical layer with benzydamine HCl and

Indexed as

bilayer filmsbiological safetymucoadhesionmucositismultidirectional releasesingle case study

Identifiers

PMID32664574
PMCPMC7408552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.